{
  "id": "bexorg-awarded-mjff-grant-to-identify-biomarkers-for-trpml1-parkinson-s-therapies",
  "title": "Bexorg awarded MJFF grant to identify biomarkers for TRPML1 Parkinson’s therapies",
  "summary": "Bexorg Inc., a neurotech company developing translational tools to accelerate central nervous system drug discovery, has been awarded a research grant by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies Initiative to help identify translational biomarkers for TRPML1-targeted Parkinson’s disease therapies, the company said. Translational biomarkers are biological signatures […] The post Bexorg awarded MJFF grant to identify biomarkers for TRPML1 Parkinson’s therapies appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/bexorg-awarded-mjff-grant-to-identify-biomarkers-for-trpml1-parkinsons-therapies/",
  "source": "Longevity.Technology",
  "author": null,
  "category": "news",
  "publishedAt": "2026-01-30T10:31:28.000Z",
  "fetchedAt": "2026-02-04T10:49:05.819Z",
  "relevanceScore": 0.5,
  "matchedKeywords": [
    "longevity",
    "biomarker"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.862Z"
}